|
Safety Study of PI-0824 to Treat Pemphigus vulgaris Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Safety Study of PI-0824 to Treat Pemphigus vulgaris conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Safety Study of PI-0824 to Treat Pemphigus vulgaris Clinical research trials and Safety Study of PI-0824 to Treat Pemphigus vulgaris health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Safety Study of PI-0824 to Treat Pemphigus vulgaris. Safety Study of PI-0824 to Treat Pemphigus vulgaris Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Safety Study of PI-0824 to Treat Pemphigus vulgaris clinical trial. Human subjects often get the best healthcare possible for their Safety Study of PI-0824 to Treat Pemphigus vulgaris condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety Study of PI-0824 to Treat Pemphigus vulgaris  Safety Study of PI-0824 to Treat Pemphigus vulgaris
Safety Study of PI-0824 to Treat Pemphigus vulgaris
For Condition: Pemphigus Vulgaris
Status: Recruiting
Sponsor(s): Peptimmune ,
Synopsis: The purpose of this study is to determine if the use of PI-0824 in patients with Pemphigus vulgaris is safe.
Details: Pemphigus vulgaris (PV) is an autoimmune disease affecting approximately 40,000 people worldwide. People with PV produce antibodies that attack the cells of the skin, resulting in blisters which, if left untreated, can lead to devastating infections and discomfort. Currently, most doctors who treat patients with PV will prescribe high-dose steroids and drugs that suppress the immune system in an effort to decrease the production of these antibodies. Unfortunately these medications are associated with serious and difficult side effects that often result in the discontinuation of their use. Peptimmune, Inc. has developed a new therapy for the treatment of PV, PI-0824. The goal of this therapy is to reduce the production of antibodies that cause PV blisters by acting only on the disease causing components of the immune system. It is hoped that use of PI-0824 will reduce or potentially eliminate the need for high dose steroids and drugs that suppress the immune system.
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Currently experiencing a stable disease course and medication regimen. Currently taking daily corticosteroid therapy for PV.
Total Enrollment: 15
Location and Contact Information:
Long Island Jewish Medical Center*Recruiting*
New Hyde Park, New York, 11040
United States
RecruitingAlyssa Echevarria 718-470-4408
University of California San Francisco*Recruiting*
San Francisco, California, 94107
United States
RecruitingCarla Maynetto 415-502-6229
Johns Hopkins School of Medicine*Recruiting*
Baltimore, Maryland, 21205
United States
RecruitingAnita Guidos 410-955-3422
East Coast Clinical Research*Recruiting*
Salisbury, Massachusetts, 01952
United States
RecruitingCynthia Owens 978-462-6789
University of Pennsylvania*Not yet recruiting*
Philadelphia, Pennsylvania, 19104
United States
Not yet recruitingJennifer Williams 215-662-2540
NYU School of Medicine*Recruiting*
New York City, New York, 10016
United States
RecruitingBruce Strober 212-263-5244
Case Western Reserve University*Recruiting*
Cleveland, Ohio, 44106
United States
RecruitingZsa Porter 216-844-5899
Additional Information:
Study ID Numbers: PI-001;
Study Start Date: July 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00063752
Other Pemphigus VulgarisStudies:
1. Safety Study of PI-0824 to Treat Pemphigus vulgaris
Related Studies:
Other Pemphigus Vulgaris Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Safety Study of PI-0824 to Treat Pemphigus vulgaris
|
|
|
|
|
|
|
|
